Extensive molecular screening for hereditary non-polyposis colorectal cancer

British Journal of Cancer

Volumn 82, Issue 4, 2000, Pages 871-880

  Dieumegard, B ^a,b   Grandjouan, S ^b   Sabourin, J C ^c   Le Bihan, M L ^a   Lefrere I ^a,d   Bellefqih, ^c   Pignon, J P ^c   Rougier, P ^c,e   Lasser, P ^c   Benard J ^a   Couturier, D ^b   Bressac de Paillerets, B ^a,c  

^a Institut Gustaye Roussy   (France)

^b Hôpital Cochin ^*  (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d Smithkline Beecham Pharmaceutical L   (France)

^e HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Colorectal cancer; hMLH1; hMSH2; Predisposition; Screening

Indexed keywords

MICROSATELLITE DNA; PROTEIN P53;

ADOLESCENT; ADULT; ARTICLE; BASE MISPAIRING; CANCER SCREENING; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DNA REPAIR; FAMILIAL CANCER; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MOLECULAR GENETICS; PRIORITY JOURNAL;

EID: 0033962257     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1014     Document Type: Article

References (67)

1. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, Chadwick RB, Kaariainen H, Eskelinen M, Jarvinen H, Mecklin JP and de la Chapelle A (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338: 1481-1487
2. Aebi S, Kurdi Haidar B, Gordon R, Cenni B, Zheng H, Fink D, Christen RD, Boland CR, Koi M, Fishel R and Howell SB (1996) Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res 56: 3087-3090
3. Akiyama Y, Sato H, Yamada T, Nagasaki H, Tsuchiya A, Abe R and Yuasa Y (1997) Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res 57: 3920-3923
4. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Milburn Jessup J, van Tuinen P, Ledbetter DH, Barker DF, Nakamura Y, White R and Vogelstein B (1989) Chromosome 17 deletions and p53 gene mutations in colorectal cancer. Science 244: 217-221
5. Benatti P, Sassatelli R, Roncucci L, Pedroni M, Fante R, Digregorio C, Losi L, Gelmini R and Deleon MP (1993) Tumour spectrum in hereditary nonpolyposis colorectal cancer (HNPCC) and in families with 'suspected HNPCC' - a population based study in northern Italy. Int J Cancer 54: 371-377
6. Bocker T, Diermann J, Friedl W, Gebert J, Holinski-Feder E, Karner-Hanush J, von Knebel-Doeberitz M. Koelble K, Moeslein G, Schackert H, Wirtz H, Fishel R and Rüschoff J (1997) Microsatellite instability analysis: a multicenter study for reliability and quality control. Cancer Res 57: 4739-4743
7. Borresen A, Lothe RA, Meling GI, Lystad S, Morrison P, Lipford J, Kane MF, Rognum TO and Kolodner RD (1995) Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas. Hum Mol Genet 4: 2065-2072
8. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A, Tannergard P, Bollag RJ, Godwin AR, Ward PC, Nordenskjold M, Fishel R, Kolodner R and Liskay RM (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368: 258-261
9. Burt RW (1996) Familial risk and colon cancer. Int J Cancer (Pred Oncol) 69: 44-46
10. Casey G, Lopez ME, Ramos JC, Plummer SJ, Arboleda MJ, Shaughnessy M, Karlan B and Slamon DJ (1996) DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene 13: 1971-1981
11. Damalas A, Ben-Ze'ev A, Simcha I, Shtutman M, Leal JF, Zhurinsky J, Geiger B and Oren M (1999) Excess beta-catenin promotes accumulation of transcriptionally active p53. EMBO J 18: 3054-3063
12. de Vathaire F, Koscielny S, Rezvani A, Laplanche A, Estève J, Ferlay J and de Vathaire F (eds) (1996) Estimation de l'incidence des cancers en France, 1983-1987. Editions INSERM: Paris
13. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R and Rüschoff J (1997) Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 57: 4749-4756
14. Drummond JT, Li G, Longley MJ and Modrich P (1995) Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. Science 268: 1909-1912
15. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J and Kolodner R (1993) The human mutator gene homolog MSH2 and its association with hereditary non polyposis colon cancer. Cell 75: 1027-1038
16. Fishel R, Ewel A, Lee S, Lescoe MK and Griffith J (1994) Binding of mismatched microsatellite DNA sequences by the human MSH2 protein. Science 266: 1403-1405
17. Fujiwara T, Stolker JM, Watanabe T, Rashid A, Longo P, Eshleman JR, Booker S, Lynch HT, Jass JR, Green JS, Kim H, Jen J, Vogelstein B and Hamilton SR (1998) Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol 153: 1063-1078
18. Futreal PA, Liu QY, Shattuckeidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugenstrano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaverfeldhaus J, Ding W, Gholami Z, Soderkvist P, Terry L, Jhanwar S, Berchuck A, et al. (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120-122
19. Genuardi M, Anti M, Capozzi E, Leonardi F, Fornasarig M, Novella E, Bellacosa A, Valenti A, Gasbarrini GB, Roncucci L, Benatti P, Percesepe A, Ponz de Leon M, Coco C, de Paoli A, Valentini M, Boiocchi M, Neri G and Viel A (1998a) MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer. Int J Cancer 75: 835-839
20. Genuardi M, Viel A, Bonora D, Capozzi E, Bellacosa A, Leonardi F, Valle R, Ventura A, Pedroni M, Boiocchi M and Neri G (1998b) Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility. Hum Genet 102: 15-20
21. Gompel A, Sabourin JC, Martin A, Yaneva H and Poitout P (1994) BCL-2 expression in the endometrium during the menstrual cycle. Am J Pathol 144: 1195-1202
22. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M and Weissenbach J (1994) The 1993-1994 Généthon human genetic linkage map. Nature Genet 7: 246-339
23. Hemminki A, Peltomaki P, Mecklin J, Järvinen H, Salovaara R, Nystöm-Lahti M, de la Chapelle A and Aaltonen LA (1994) Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nature Genet 8: 405-410
24. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JPJ, Markowitz S, Willson JKV, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA and Baylin SB (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95: 6870-6875
25. Ionov Y, Peinado MA, Malkhosyan S, Shibata D and Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363: 558-561
26. Janin N (2000) A simple model for carcinogenesis of colorectal cancers with microsatellite instability. Adv Cancer Res 77: 189-221
27. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM and Kolodner R (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell line. Cancer Res 57: 808-811
28. Kinzler K and Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87: 159-170
29. Kinzler KW and Vogelstein B (1997) Gatekeepers and caretakers. Nature 386: 761-763
30. Kohonen-Corish M, Ross VL, Doe WF, Kool DA, Edkins E, Faragher I, Wijnen J, Meera Khan P, Macrae F and St John DJB (1996) RNA-based mutation screening in hereditary nonpolyposis colorectal cancer. Am J Hum Genet 59: 818-824
31. Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Onda A, Okumura Y, Kishi N, Iwama T, Mori T, Koike M, Ushio K, Chiba M, Nomizu S, Konishi F, Utsunomiya J and Miyaki M (1996) Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 111: 307-317
32. Kowalski LD, Mutch DG, Herzog TJ, Rader JS and Goodfellow PJ (1997) Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers. Genes Chromosomes Cancer 18: 219-227
33. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Aaltonen LA, Nystromlahti M, Guan XY, Zhang J, Meltzer PS, Yu JW, Kao FT, Chen DJ, Cerosaletti KM, Fournier REK, Todd S, Lewis T, et al. (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75: 1215-1225
34. Liu B, Farrington SM, Petersen GM, Hamilton SR, Parsons R, Papadopoulos N, Fujiwara T, Jen J, Kinzler KW, Wyllie AH, Vogelstein B and Dunlop MG (1995a) Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med 1: 348-352
35. Liu B, Nicolaides NC, Markowitz S, Willson JKV, Parsons RE, Jen J, Papadopoulos N, Peltomäki P, de la Chapelle A, Hamilton SR, Kinzler KW and Vogelstein B (1995b) Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 9: 48-55
36. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, Jass JR, Dunlop M, Wyllie A, Peltomaki P, de la Chapelle A, Hamilton SR, Vogelstein B and Kinzler KW (1996) Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2: 169-174
37. Losi L, Ponz de Leon M, Jirieny J, Di Gregorio C, Benatti P, Percesepe A, Fante R, Roncucci L, Pedroni M and Benhattar J (1997) K-ras and p53 mutations in hereditary non-polyposis colorectal cancers. Int J Cancer 74: 94-96
38. Lu S, Kawabata M, Imamura T, Akiyama Y, Nomizu T, Miyazono K and Yuasa Y (1998) HNPCC associated with germline mutation in the TGFβ type II receptor gene. Nat Genet 19: 17-18
39. Lynch HT and Smyrk T (1996) Hereditary non-polyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 78: 1149-1167
40. Lynch HT, Ens J, Lynch JF and Watson P (1988) Tumor variation in three extended Lynch syndrome II kindreds. Am J Gastroenterol 83: 741-747
41. Lynch HT, Smyrk T and Lynch JF (1996) Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch syndrome). Int J Cancer (Pred Oncol) 69: 38-43
42. Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C and Franck TS (1995) Somatic mutations in the BRCAI gene in sporadic ovarian tumours. Nature Genet 9: 439-443
43. Midgley CA and Lane DP (1997) p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding. Oncogene 15: 1179-1189
44. Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Yasuno M, Igari T, Koike M, Chiba M and Mori T (1997) Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 17: 271-272
45. Mori Y, Shiwaku H, Fukushige S, Wakatsuki S, Sato M, Nukiwa T and Horii A (1997) Alternative splicing of hMSH2 in normal human tissues. Hum Genet 99: 590-595
46. Moslein G, Tester DJ, Lindor NM, Honchel R, Cunningham JM, French AJ, Halling KC, Schwab M, Goretzki P and Thibodeau SN (1996) Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet 5: 1245-1252
47. Munemitsu S, Albert I, Souza B, Rubinfeld B and Polakis P (1995) Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 92: 3046-3050
48. Nicolaides NC, Papadopoulos N, Liu B, Wei Y, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Dunlop MG, Hamilton SR, Petersen GM, de la Chapelle A, Vogelstein B and Kinzler KW (1994) Mutations of two PMS homologs in hereditary non polyposis colon cancer. Nature 371: 75-80
49. Nicolaides NC, Littman SJ, Modrich P, Kinzler KW and Vogelstein B (1998) A naturally occurring hPMS2 mutation can confer a dominant negative mutator phenotype. Mol Cell Biol 18: 1635-1641
50. Olschwang S, Hamelin R, Laurent-Puig P, Thuille B, De Rycke Y, Li Y, Muzeau F, Girodel J, Salmon R and Thomas G (1997) Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci USA 94: 12122-12123
51. Orth K, Hung J, Gazdar A, Bowcock A, Mathis M and Sambrook J (1994) Genetic instability in human ovarian cancer cell lines. Proc Natl Acad Sci USA 91: 9495-9499
52. Papadopoulos N, Nicolaides N, Wei Y, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Petersen GM, Watson P, Lynch HT, Peltomäki P, Mecklin J, de la Chapelle A, Kinzler K and Vogelstein B (1994) Mutation of a mutL homolog in hereditary colon cancer. Science 263: 1625-1629
53. Parsons R, Myeroff LL, Liu B, Willson JKV, Markowitz SD, Kinzler KW and Vogelstein B (1995) Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res 55: 5548-5550
54. Prolla TA, Pang Q, Alani E, Kolodner RD and Liskay RM (1994) MLH1, PMS1, and MSH2 interactions during the initiation of DNA mismatch repair in yeast. Science 265: 1091-1093
55. Richards B, Zhang H, Phear G and Meuth M (1997) Conditional mutator phenotypes in hMSH2-deficient tumor cell lines. Science 277: 1523-1526
56. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L and Srivastava S (1997) A National Cancer Institute workshop on Hereditary Non-polyposis Colorectal Cancer: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89: 1758-1762
57. Shimodaira H, Filosi N, Shibata H, Suzuki T, Radice P, Kanamaru R, Friend SH, Kolodner RD and Ishioka C (1998) Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae. Nature Genentic 19: 384-389
58. Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, Stoppa-Lyonnet D, the French Familial Melanoma Study Group. Bénard J and Bressac-de Paillerets B (1998) Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. Hum Mol Genet 7: 209-216
59. Thibodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, Lindor MM, Moslein G, Baker SM, Liskay RM, Burgart LJ, Honchel R and Halling KC (1996) Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 56: 4836-4840
60. Tomlinson IP, Beck NE, Homfray T, Harocopos CJ and Bodmer WF (1997) Germline HNPCC gene variants have little influence on the risk for sporadic colorectal cancer. J Med Genet 34: 39-42
61. Vasen HFA, Offerhaus GJA, den Hartog Jager FCA, Menko FH, Nagengast FM, Griffioen G, van Hogezand RB and Heintz APM (1990) The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 kindreds in the Netherlands. Int J Cancer 46: 31-34
62. Vasen HFA, Mecklin J, Meera Khan P and Lynch HT (1991) The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICGHNPCC). Dis Colon Rectum 34: 424-425
63. Vasen HFA, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, Nagengast FM, Meijers-Heijboer EH, Bertario L, Varesco L, Bisgaard M, Mohr J, Fodde R and Meera Khan P (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110: 1020-1027
64. Wang Q, Desseigne F, Lasset C, Saurin J, Navarro C, Yagei T, Keser I, Bagei H, Luleci G, Gelen T, Chayvialle J, Puisieux A and Ozturk M (1997) Germline hMSH2 and hMLH1 gene mutations in incomplete HNPCC families. Int J Cancer 73: 831-836
65. Watson P and Lynch HT (1993) Extracolonic cancer in hereditary non-polyposis colorectal cancer. Cancer 71: 677-685
66. Weber T (1996) Clinical surveillance recommendations adopted for HNPCC. Lancet 348: 465
67. Xia L, Shen W, Ritacca F, Mitri A, Madlensky L, Berk T, Cohen Z, Gallinger S and Bapat B (1996) A truncated hMSH2 transcript occurs as a common variant in the population: implication for genetic diagnosis. Cancer Res 56: 2289-2292